Exosens (EPA:EXENS)
France flag France · Delayed Price · Currency is EUR
39.65
-0.75 (-1.86%)
Aug 8, 2025, 5:35 PM CET

Theseus Pharmaceuticals Revenue

Exosens had revenue of 224.50M EUR in the half year ending June 30, 2025, with 79.60% growth. This brings the company's revenue in the last twelve months to 431.68M, up 22.04% year-over-year. In the year 2024, Exosens had annual revenue of 394.08M with 35.04% growth.

Revenue (ttm)
431.68M
Revenue Growth
+22.04%
P/S Ratio
4.66
Revenue / Employee
308.36K
Employees
1,401
Market Cap
2.01B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024394.08M102.26M35.04%
Dec 31, 2023291.82M91.07M45.36%
Dec 31, 2022200.75M34.58M20.81%
Dec 31, 2021166.17M16.31M10.88%
Dec 31, 2020149.86M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Airbus SE70.02B
Schneider Electric S.E.39.32B
Safran29.38B
Vinci73.73B
Compagnie de Saint-Gobain46.96B
Thales21.35B
Legrand9.21B
Veolia Environnement44.60B
Revenue Rankings